Updated monthly
Drug Pricing & Access
Original pricing datasets, self-pay cost tracking, and insurance coverage analysis across branded and compounded GLP-1 medications.
Coming soon
Research Areas
Six domains of independent inquiry
Each research area maintains its own verification cadence, sourcing standards, and editorial review process. Publications are released as they meet our quality threshold.
FDA-sourced data
Comparative Efficacy
Head-to-head analysis of weight loss outcomes, A1C reduction, and cardiovascular endpoints across the GLP-1 receptor agonist class.
Coming soon
Label-verified
Safety & Tolerability
Adverse event profiles, contraindication mapping, and real-world tolerability data synthesized from prescribing information and published trials.
Coming soon
Real-time tracking
Pipeline & Approvals
Tracking next-generation molecules — orforglipron, survodutide, retatrutide, amycretin — from Phase III through FDA decision dates.
Coming soon
50+ providers tracked
Telehealth & Access
Provider landscape analysis, prescribing pattern data, and accessibility research across the GLP-1 telehealth ecosystem.
Coming soon
Federal & state
Policy & Regulation
FDA guidance analysis, compounding regulation, Medicare Part D coverage policy, and state-level access legislation tracking.
Coming soon
Methodology
How we verify every claim
Every data point published in The RX Index Research follows a structured verification pipeline. We do not rely on press releases, manufacturer marketing materials, or secondary reporting.
01
Primary Source Identification
FDA prescribing information, ClinicalTrials.gov, and official manufacturer SEC filings.
02
Cross-Referencing
Every claim checked against at least two independent sources before publication.
03
Medical Review
Licensed pharmacists and physicians review all clinical content.
04
Ongoing Verification
Pricing and availability data re-verified on a monthly cycle.
Source Hierarchy
Ranked by authority — higher tiers override lower
Tier 1Primary
FDA prescribing information & labels
Tier 2Primary
Published clinical trial results (peer-reviewed)
Tier 3Primary
ClinicalTrials.gov registry data
Tier 4Verified
Official manufacturer pricing pages
Tier 5Verified
SEC filings & investor presentations
Tier 6Secondary
Medical society guidelines (ADA, AHA, TOS)
Editorial Standards
Built on four principles
These standards apply to every piece of research we publish — without exception.
FDA-Sourced
All clinical claims verified against current FDA prescribing information and official labeling.
Conflict-Free
Research content is editorially independent — no sponsor influence, no pay-for-placement.
Medically Reviewed
Every publication reviewed by licensed pharmacists and physicians before release.
Open Methodology
Our verification process, data sources, and analytical frameworks are fully documented.
Publications
Research publications launching soon
We're preparing our first wave of open-access research publications. Each will include full methodology documentation, source citations, and downloadable datasets where applicable.
Initial publications in development